Financial Review: Spectral AI (NASDAQ:MDAI) versus Inspira Technologies Oxy B.H.N. (NASDAQ:IINN)

Spectral AI (NASDAQ:MDAI) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, earnings, valuation and dividends.

Earnings & Valuation

This table compares Spectral AI and Inspira Technologies Oxy B.H.N.”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$22.53 million	1.11	-$20.85 million	($0.65)	-2.08
Inspira Technologies Oxy B.H.N.	N/A	N/A	-$11.29 million	N/A	N/A

Inspira Technologies Oxy B.H.N. has lower revenue, but higher earnings than Spectral AI.

Risk and Volatility

Spectral AI has a beta of 0.48, suggesting that its stock price is 52% less volatile than the S&P 500. Comparatively, Inspira Technologies Oxy B.H.N. has a beta of 2.08, suggesting that its stock price is 108% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Spectral AI and Inspira Technologies Oxy B.H.N., as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	0	0	3	1	3.25
Inspira Technologies Oxy B.H.N.	0	0	0	0	0.00

Spectral AI presently has a consensus target price of $4.50, suggesting a potential upside of 233.33%. Given Spectral AI’s stronger consensus rating and higher possible upside, equities research analysts clearly believe Spectral AI is more favorable than Inspira Technologies Oxy B.H.N..

Profitability

This table compares Spectral AI and Inspira Technologies Oxy B.H.N.’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Spectral AI	-40.78%	N/A	-75.31%
Inspira Technologies Oxy B.H.N.	N/A	N/A	N/A

Insider and Institutional Ownership

67.1% of Spectral AI shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. 56.7% of Spectral AI shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Spectral AI beats Inspira Technologies Oxy B.H.N. on 7 of the 11 factors compared between the two stocks.

About Spectral AI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.